These findings suggest that C5a creates an immunosuppressive tumor microenvironment, promoting tumor growth [23], supporting the rationale of blockade of C5aR to increase the efficacy of future therapeutic strategies for cancers. The gene discussed is C5AR1; the disease is neoplasm.